Norwegian biotechnology
GlycaNova is an innovative Norwegian biotechnology company focused on the modulation of the immune system using proprietary 1,3 beta-glucans derived from medicinal mushrooms.
GlycaNova’s beta-glucans are scientifically proven to be significantly more bioavailable and bioactive than other beta-glucans owing to GlycaNova’s unique manufacturing process which preserves the beta-glucans’ triple helix three-dimensional structure, thereby optimising absorption and biological activity.
GlycaNova has developed clinically proven consumer healthcare products for immune system support and problematic skin conditions and also focuses on animal health.